MENU

Click below to download The Novozymes Report 2015 in PDF format.

  •  The big picture
  •  Our business
  •  Governance
  •  Accounts and performance
  •  Supplementary

Board of Directors

Henrik Gürtler*

Born 1953. Chairman of the Board since 2000. Elected for one year at a time.

Board positions

Member:
Ejendomsmægler Kim Svane A/S

Special competencies

In-depth knowledge of Novozymes’ business, and expertise in managing and working in an international biotechnology company.

 

* This board member is not regarded as independent in the sense of the definition in the Danish Recommendations on Corporate Governance that apply to Danish listed companies.

Agnete Raaschou-Nielsen

Born 1957. Vice Chairman of the Board since 2014. Member of the Board since 2011. Member of the Audit Committee. Elected for one year at a time.

Board positions

Chairman:
Arkil Holding A/S
Brdr. Hartmann A/S

Deputy Chairman:
Dalhoff Larsen & Horneman A/S
Danske Invest
Solar A/S

Member:
Aktieselskabet Schouw & Co.
Danske Invest Management A/S
Icopal Holding A/S

Member of the Audit Committee:
Aktieselskabet Schouw & Co.
Solar A/S

Special competencies

Expertise within business development and acquisitions, macroeconomics and intellectual property rights.

Heinz-Jürgen Bertram

Born 1958. President & CEO, Symrise AG (Germany). Member of the Board since 2015. Elected for one year at a time.

Board Positions

Member:
Rockwool A/S
Nord/LB Holzminden
Deutsche Bank Hannover

Special competencies

International business and management experience, and experience in converting research and biotechnology into commercial products and solutions.

Lars Green*

Born 1967. Senior Vice President, Finance & Operations, Novo Nordisk Inc. (U.S.). Member of the Board since 2014. Chairman of the Audit Committee. Elected for one year at a time.

Special competencies

In-depth knowledge of the Novo Group's business, international experience from managing global biotech and biopharma companies, and financial and accounting expertise.

* This board member is not regarded as independent in the sense of the definition in the Danish Recommendations on Corporate Governance that apply to Danish listed companies.

Lena Olving

Born 1956. President & CEO, Mycronic AB (publ), Sweden. Member of the Board since 2011. Member of the Audit Committee. Elected for one year at a time.

Board positions

Elected fellow of the Royal Swedish Academy of Engineering Sciences (IVA).

Special competencies

Expertise within sales and marketing, supply chain, process optimization and production, and broad experience in finance and accounting matters.

Jørgen Buhl Rasmussen

Born 1955. Adjunct Professor at Copenhagen Business School. Member of the Board since 2011. Elected for one year at a time.

Board positions

Member:
IFC Europe A/S

Advisory Board:
Axcel

Special competencies

International business and management experience, specifically within sales, marketing, branding and acquisitions.

Mathias Uhlén

Born 1954. Professor at the Royal Institute of Technology (KTH) in Sweden and the Technical University of Denmark (DTU). Member of the Board since 2007. Elected for one year at a time.

Board positions

Chairman:
Atlas Antibodies AB
Antibodypedia AB

Vice Chairman:
Affibody AB

Member:
Alligator AB
Bure Equity AB
Swetree Technologies AB

Special competencies

Broad experience in research and biotechnology.

Lena Bech Holskov

Born 1967. Safety Adviser. Employee representative. Member of the Board since 2013. Elected for four years at a time.

Anders Hentze Knudsen

Born 1959. Senior Operator. Employee representative. Member of the Board since 2013. Elected for four years at a time.

Lars Bo Køppler

Born 1962. Technician. Employee representative. Member of the Board since 2010. Elected for four years at a time.

Board positions

Member:
Novo Nordisk Foundation